Cernos Gel
Testosterone gel for male hypogonadism. It is a topical treatment absorbed through the skin over time.
- Category
- Hormone Therapy
- Active ingredient
- Testosterone
- Route
- Transdermal use
- Form
- Gel
- Strengths
- 1% 5gm
Prescription and consultation requirements for Cernos Gel vary by destination and are determined by the fulfilment partner.
Cernos Gel details
- Condition
- Male Hypogonadism
- Alternative names
- testosterone
- Therapeutic class
- Androgen
- Pharmacological class
- Testosterone replacement
- Contraindications
- breast cancer in males; known or suspected prostate cancer; pregnancy
- Minor side effects
- acne; local skin irritation
- Moderate side effects
- prostate-specific antigen elevation; increased haematocrit; headache
- Dosage forms
- Gel
- Administration route
- Transdermal use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Sun Pharmaceutical Industries Ltd
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Insulin; Oral Anticoagulants
- Age restrictions
- Approved for adult males.
Serious side effects
deep vein thrombosis, requires immediate medical attention; prostatic hyperplasia progression, requires immediate medical attention
Patient summary
Testosterone gel for male hypogonadism. It is a topical treatment absorbed through the skin over time.
Mechanism of action
Provides continuous physiological levels of testosterone, regulating cellular DNA transcription to restore male reproductive characteristics.
Pregnancy and breastfeeding
Pregnancy: Highly contraindicated. Can cause severe virilisation of female fetuses. Breastfeeding: Not applicable.